Federica Marelli

Dr. Federica Marelli


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2020 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
GRGiuditta Rurale
Giuditta Rurale
ECEmery Di Cicco
Emery Di Cicco
MDMonica Dentice
Monica Dentice
DSDomenico Salvatore
Domenico Salvatore
LPLuca Persani
Luca Persani
CLCristina Luongo
Cristina Luongo
Thyroid hormone action defects (THADs) have been classically considered conditions of impaired sensitivity to thyroid hormone (TH). They were originally referring to alterations in TH receptor genes (THRA and THRB), but the discovery of genetic mutations and polymorphisms causing alterations in cell membrane transport (e.g., MCT8) and metabolism (e.g., SECISBP2, DIO2) led recently to a new and broader definition of TH hyposensitivity (THH), including not only THADs but all defects that could interfere with the activity of TH. Due to the different functions and tissue-specific expression of these genes, affected patients exhibit highly variable phenotypes. Some of them are characterized by a tissue hypothyroidism or well-recognizable alterations in the thyroid function tests (TFTs), whereas others display a combination of hypo- and hyperthyroid manifestations with normal or only subtle biochemical defects. The huge effort of basic research has greatly aided the comprehension of the molecular mechanisms underlying THADs, dissecting the morphological and functional alterations on target tissues, and defining the related-changes in the biochemical profile. In this review, we describe different pictures in which a specific alteration in the TFTs (TSH, T4, and T3 levels) is caused by defects in a specific gene. Altogether these findings can help clinicians to early recognize and diagnose THH and to perform a more precise genetic screening and therapeutic intervention. On the other hand, the identification of new genetic variants will allow the generation of cell-based and animal models to give novel insight into thyroid physiology and establish new therapeutic interventions.

2 March 2016
Verified
Journal Article
Closed access
IBIvan Bassi
Ivan Bassi
VAValentina André
Valentina André
FMFederica Marelli
Federica Marelli
VVValeria Vezzoli
Valeria Vezzoli
GMGiorgio R Merlo
Giorgio R Merlo
MBMarco Bonomi
Marco Bonomi

3 May 2017 in Endocrine Abstracts
Verified
Journal Article
Closed access
FMFederica Marelli
Federica Marelli
GRGiuditta Rurale
Giuditta Rurale
SCSilvia Carra
Silvia Carra
LPLuca Persani
Luca Persani
Anaemia in RTHα patients correlates with documented abnormal erythropoiesis and reduced haematocrit in TRα-null or mutant mice, but the underlying mechanisms and characterization of the defect remain elusive. In a previous work, we described that the injection of several hTRα variants in zebrafish eggs caused a marked reduction of circulating erythrocytes at later stages of the erythropoiesis. To characterise the involvement of TRα during erythrocyte development, we analysed by qRT-PCR and in situ hybridization (ISH) the expression of different haematopoietic markers. We microinjected the zebrafish eggs at 1–2 cells stage with 80pg/embryos of the purified mRNAs of several hTRα variants, and from the 6-hpf, the injected embryos were treated with the control vehicle, or with 20 μM-T3, added in the harvested water. By qRT-PCR, the expression of genes involved in the specification of lateral mesoderm (cdx4, bmp2b, smad5, chd), induction and proliferation of haematopoietic stem cells (HSC) (tal1, lmo2, gata1, gata2) and proliferation of erythrocytes (zin, grx5, cia, cha) appeared significantly reduced in all hTRα-injected embryos. Consistent with previous results, the treatment with high T3 doses can rescue the DN-activity of the missense variants D211G and A263V, whereas the truncated receptors A382PfsX7, E403X and F397fs406X are unaffected by TH treatment. Furthermore, we analysed the specification of HSC in embryos at 8-somite stage, by ISH. The vast majority of the hTRα-injected embryos showed a reduced or undetectable expression of early erythropoiesis markers, such as c-myb, pu.1, tal1 and gata1 in anterior or posterior lateral mesoderm. At 36-hpf, we also observed a dramatic reduction of gata1 in the intermediated cell mass of hTRα-injected embryos. Therefore, our results highlight a relevant role for TRα during the early phases of the primitive haematopoiesis, when the HSC start to proliferate and differentiate. Research founding: IAI-Ricerca Corrente RF-2011 05C102.

3 May 2017 in Endocrine Abstracts
Verified
Journal Article
Closed access
IBIvan Bassi
Ivan Bassi
FMFederica Marelli
Federica Marelli
VVValeria Vezzoli
Valeria Vezzoli
LPLuca Persani
Luca Persani
YGYoav Gothilf
Yoav Gothilf
MBMarco Bonomi
Marco Bonomi
Studies conducted using knockout mouse model revealed that defects of PROKR2 affect the correct ontogeny of GnRH neurons and, by consequence, neuroendocrine control of reproduction. Nevertheless its exact role during these processes and in the pathogenesis of congenital hypogonadotropic hypogonadism (CHH) remains elusive due to the phenotypic differences observed between mouse and human. Zebrafish (ZF) has emerged in the last ten years as a reliable model organism for studying the GnRH neuronal development and the neuroendocrinology of reproduction. Previous results obtained in our lab identified two well-conserved loci in the ZF genome, on chr1 and chr13, respectively named prokr1a and prokr1b. Whole mount in situ hybridization (WISH) and qRT-PCR experiments conducted at different developmental stages of ZF revealed distinct patterns of expression for prok-receptors suggesting prokr1b as the potential candidate involved in the GnRH-secreting neurons migration process from olfactory placode to their final hypothalamic destination. To verify these indications and better elucidate the function of both prokineticins receptors we recently conducted knockdown experiments using morpholino oligonucleotides sequences. Our results display an alteration of the GnRH fibers network architecture at 48 hours post fertilization (hpf) after downregulation of prokr1b that appeared misguided and reduced in numbers especially at level of pallium commissure and optic chiasm. Moreover, we also generated in ZF the prokr1b knockout model and our preliminary data are confirming the knockdown model observations. On the contrary, the downregulation of prokr1a does not affect GnRH fibers architecture. Taken together these results confirm the role of prokr1b during GnRH neurons migration establishing it as the ZF orthologous of human PROKR2. A deeper characterization of ZF prokr1b KO model could provide new information regarding the early establishment of the forebrain GnRH system, the factors controlling this complex developmental event, and its functional significance. This work was supported by funds from University of Milan (Dotazione per attività istituzionali—Linea 2 azione B Piano di Sviluppo di Ateneo) and IRCCS Istituto Auxologico Italiano (Ricerca Corrente Funds: 05C202 and GONAFISH). Funds: 05C202 and GONAFISH).

13 May 2016 in Endocrine Abstracts
Verified
Journal Article
Closed access
FMFederica Marelli
Federica Marelli
SCSilvia Carra
Silvia Carra
GRGiuditta Rurale
Giuditta Rurale
FCFranco Cotelli
Franco Cotelli
LPLuca Persani
Luca Persani
Introduction: Since 2012, different heterozygous mutations in the THRA gene have been described in patients with resistance to thyroid hormone alpha (RTHα). The associating symptoms are reminiscent of untreated congenital hypothyroidism (growth retardation, psycho-neuromotor disorders, delayed bone development and bradycardia) but with raised T3/T4 ratio and normal TSH levels. All genetic abnormalities act in a dominant negative (DN) manner against functional receptors due to reduced T3-binding or defective interaction with corepressors or coactivators of the ligand-binding domain. Therefore, RTHα patients present variable sensitivity to TH treatment. We previously described that zebrafish embryos expressing a DN form of thraa recapitulate the key features of RTHα, and that zebrafish and human receptors are functionally interchangeable. Methods: In this work, we present a simplified model obtained by direct mRNA microinjection into zebrafish eggs of several human THRA variants (D211G, A263V, A382PfsX7, E403X and F397fs406X). Using a series of molecular and analytical approaches (WISH, IHC, ELISA) we studied the embryonic development of cardiovascular, skeletal and nervous systems, which are directly involved in the T3-dependent TRα action. Additionally, thyroid and pituitary function, as well as the T3 and T4 contents were analysed. Results: All THRA-injected embryos show defects in several tissues of variable entity: altered cardiovascular development, incomplete formation of cartilages and bones, reduced number motorneurons that is reflected by defective zebrafish locomotion. Furthermore, changes in deiodinases expression (high dio2, low dio3a and dio3b levels) in presence of normal thyroid and pituitary markers, could explain the high T3/T4 ratio observed in THRA-injecting embryos, as in RTHα cases. Interestingly, the treatment with high T3 dose efficiently rescue most of these defects only in D211G- and A263V-injected embryos, conserving part of the T3-binding activity and transactivation properties. Conclusion: Zebrafish represent a new ‘biotool’ to delineate the functional impact of new THRA variants in vivo.

17 April 2014 in Endocrine Abstracts
Verified
Journal Article
Closed access
Natascia TisoNatascia Tiso
Natascia Tiso
GBGiorgia Busolin
Giorgia Busolin
OEOlivier Ek
Olivier Ek
FMFederica Marelli
Federica Marelli
PPPatrizia Porazzi
Patrizia Porazzi
Francesco ArgentonFrancesco Argenton
Francesco Argenton
In the last decades, the tropical teleost zebrafish (Danio rerio) has proved to be an excellent vertebrate system to model mammalian molecular events occurring during embryonic development, organ formation and adult physiology, either under normal or pathological conditions. Low costs and small dimensions, external fertilization and high fecundity, tissue transparency, rapid development, availability of mutant and transgenic lines, easy manipulability for gene perturbation and pharmacological screening, are some examples of the advantages characterizing this model organism. In the past 15 years, the use of zebrafish in the endocrinology field has been mainly focused on the analysis of endocrine organ development. Our team and other research groups have elucidated the main steps leading to the formation of endocrine glands such as pancreatic islets and thyroid, hypothalamus and pituitary, interrenal gland and gonads. Comparison of the zebrafish endocrine system to that of mammals has demonstrated that the systems are sufficiently similar for zebrafish to be employed as a model for endocrine research. In more recent years, new zebrafish-based tools have been generated to elucidate in vivo the molecular cross-talks occurring among cells, tissues and organs. Signalling pathway reporter lines represent an interesting implementation of classical transgenesis to visualize in vivo, in an intact organism, the anatomical regions that, in a given time interval, are responding to a specific signalling pathway. To generate these transgenic fish lines, signal-specific responsive sequences, identified at the genomic level, are multimerized and placed upstream of reporter genes, typically encoding for fluorescent proteins such as GFP or mCherry. At present, a series of pathway reporter lines are already available, among which Bmp, Shh, FGF, Notch, TGFβ, Wnt, hypoxia and glucocorticoid signalling. Our group is currently generating and validating additional lines, among which the cAMP/CREB pathway, while others, such as thyroid hormone and Foxo signalling, are in the planning phase. Preliminary results and envisaged applications will be presented and discussed.